Latest Market Research Reports

  Bioinformatics Industry The global bioinformatics market size was valued at USD 10.1 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 13.7% from 2023 to 2030. Growing demand in the process of novel drug R&D and private and public funding initiatives to support R&D activities are expected to be the key factors driving the market during the forecast period. Furthermore, the introduction of user-friendly and readily available bioinformatics software such as RasMol, AUTODOCK, BALL, and Bioclipse, and growing market usage of these tools for the accurate and effective analysis of biomarkers discovery programs that assist in toxicity detection during the initial stage of the drug development process are expected to drive industry growth over the forecast period. Bioinformatics software and tools are being used as integrated solutions that provide algorithms and statistical methodologies for data analysis and help integrate data management and...

  Bioinformatics Industry The global  bioinformatics market  is expected to reach USD 28.5 billion by 2030, registering a CAGR of 13.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. Growing clinical development of biopharmaceutical and increasing need for three-dimensional drug designing technology are expected to drive the market growth over the next five years. Furthermore, the development of bioinformatics tools and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market. Increasing demand for faster development of novel API and biopharmaceuticals is also expected to enhance the growth of this industry. Growth in the number of research and development studies in various ‘-omics’ related segments and the need for integration of the large amounts of biological data generated from these studies are also expected to encourage industry players to de...

  Bioinformatics Industry Overview The global bioinformatics market size was valued at USD 10.1 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 13.7% from 2023 to 2030. Growing demand in the process of novel drug R&D and private and public funding initiatives to support R&D activities are expected to be the key factors driving the market during the forecast period. Furthermore, the introduction of user-friendly and readily available bioinformatics software such as RasMol, AUTODOCK, BALL, and Bioclipse, and growing market usage of these tools for the accurate and effective analysis of biomarkers discovery programs that assist in toxicity detection during the initial stage of the drug development process are expected to drive industry growth over the forecast period. Gather more insights about the market drivers, restrains and growth of the  Bioinformatics Market Bioinformatics software and tools are being used as integrated solution...